Package 51662-1434-1

Brand: heparin sodium

Generic: heparin sodium
NDC Package

Package Facts

Identity

Package NDC 51662-1434-1
Digits Only 5166214341
Product NDC 51662-1434
Product ID 51662-1434_2b3948f4-fde7-5321-e063-6394a90ad70c
Description

1 mL in 1 VIAL, MULTI-DOSE (51662-1434-1)

Marketing

Marketing Status
Marketed Since 2020-01-10
Brand heparin sodium
Generic heparin sodium
Sample Package No

Linked Drug Pages (1)

HEPARIN SODIUM ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "2b3948f4-fde7-5321-e063-6394a90ad70c", "openfda": {"upc": ["0363739964112"], "unii": ["ZZ45AB24CA"], "rxcui": ["1362831"], "spl_set_id": ["9bd0f982-30f4-4e38-e053-2a95a90a3e15"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL, MULTI-DOSE (51662-1434-1)", "package_ndc": "51662-1434-1", "marketing_start_date": "20200110"}], "brand_name": "HEPARIN SODIUM", "product_id": "51662-1434_2b3948f4-fde7-5321-e063-6394a90ad70c", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-coagulant [EPC]", "Heparin [CS]", "Unfractionated Heparin [EPC]"], "product_ndc": "51662-1434", "generic_name": "HEPARIN SODIUM", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "HEPARIN SODIUM", "active_ingredients": [{"name": "HEPARIN SODIUM", "strength": "10000 [USP'U]/mL"}], "application_number": "ANDA203198", "marketing_category": "ANDA", "marketing_start_date": "20200110", "listing_expiration_date": "20261231"}